Part Details | BUPROPION HYDROCHLO
6505-01-498-3167
Alternate Parts: NDC00591354160, NDC00591-3541-60, NDC00591354160, NDC00591-3541-60, NDC00185041560, NDC00185-0415-60, NDC00173013555, NDC00173-0135-55, NDC00185041560, NDC00185-0415-60, 020957, 02-0957, NDC00173013555, NDC00173-0135-55, WELLBUTRIN, 6505-01-498-3167, 01-498-3167, 6505014983167, 014983167
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-498-3167
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC00591-3541-60 | 6LMB8 | ACTAVIS PHARMA, INC. |
| NDC00591-3541-60 | 1XUY5 | AMERISOURCEBERGEN DRUG CORPORATIONDIV CORPORATE OFFICE |
| NDC00185-0415-60 | 1XUY5 | AMERISOURCEBERGEN DRUG CORPORATIONDIV CORPORATE OFFICE |
| NDC00173-0135-55 | 1XUY5 | AMERISOURCEBERGEN DRUG CORPORATIONDIV CORPORATE OFFICE |
| NDC00185-0415-60 | 00E55 | CARDINAL HEALTH, INC.DBA CARDINAL HEALTH |
| 02-0957 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| NDC00173-0135-55 | 34006 | GLAXO WELLCOME INC |
| WELLBUTRIN | 34006 | GLAXO WELLCOME INC |
Technical Data | NSN 6505-01-498-3167
| Characteristic | Specifications |
|---|---|
| SPECIAL FEATURES | 150MG BUPROPION HYDROCHLORIDE PER EACH SUSTAINED RELEASE TABLET;60 PER BOTTLE; STORE IN TIGHT, LIGHT RESISTANT CONTAINER AT CONTROLLED ROOM TEMP BETWEEN 20-25 DEG C |
| AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER | 281604 |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | BUPROPION HYDROCHLORIDE SUSTAINED RELEASE TABLETS 150MG 60S |